HEADER    MEMBRANE PROTEIN, TRANSPORT PROTEIN     18-APR-08   2K33              
TITLE     SOLUTION STRUCTURE OF AN N-GLYCOSYLATED PROTEIN USING IN VITRO        
TITLE    2 GLYCOSYLATION                                                        
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: ACRA;                                                      
COMPND   3 CHAIN: A;                                                            
COMPND   4 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: CAMPYLOBACTER JEJUNI;                           
SOURCE   3 GENE: CMEA;                                                          
SOURCE   4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   5 EXPRESSION_SYSTEM_STRAIN: BL21(DE);                                  
SOURCE   6 EXPRESSION_SYSTEM_VECTOR: PET24B                                     
KEYWDS    GLYCOPROTEIN, N-GLYCAN, GLYCOSYLATION, MEMBRANE PROTEIN, TRANSPORT    
KEYWDS   2 PROTEIN                                                              
EXPDTA    SOLUTION NMR                                                          
NUMMDL    20                                                                    
AUTHOR    V.SLYNKO,M.SCHUBERT,S.NUMAO,M.KOWARIK,M.AEBI,F.H.-T.ALLAIN            
REVDAT   4   06-NOV-24 2K33    1       REMARK                                   
REVDAT   3   20-OCT-21 2K33    1       SEQADV HETSYN                            
REVDAT   2   29-JUL-20 2K33    1       COMPND REMARK SEQADV HETNAM              
REVDAT   2 2                   1       HETSYN LINK   SITE   ATOM                
REVDAT   1   03-FEB-09 2K33    0                                                
JRNL        AUTH   V.SLYNKO,M.SCHUBERT,S.NUMAO,M.KOWARIK,M.AEBI,F.H.ALLAIN      
JRNL        TITL   NMR STRUCTURE DETERMINATION OF A SEGMENTALLY LABELED         
JRNL        TITL 2 GLYCOPROTEIN USING IN VITRO GLYCOSYLATION.                   
JRNL        REF    J.AM.CHEM.SOC.                V. 131  1274 2009              
JRNL        REFN                   ISSN 0002-7863                               
JRNL        PMID   19154179                                                     
JRNL        DOI    10.1021/JA808682V                                            
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : TOPSPIN 2.0, CYANA                                   
REMARK   3   AUTHORS     : BRUKER BIOSPIN (TOPSPIN), GUNTERT, MUMENTHALER AND   
REMARK   3                 WUTHRICH (CYANA)                                     
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 2K33 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-MAY-08.                  
REMARK 100 THE DEPOSITION ID IS D_1000100614.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 303                                
REMARK 210  PH                             : 6.4                                
REMARK 210  IONIC STRENGTH                 : 50                                 
REMARK 210  PRESSURE                       : AMBIENT                            
REMARK 210  SAMPLE CONTENTS                : 1 MM [U-100% 15N] ACRA, 1 MM       
REMARK 210                                   SUGAR (7-MER), 50 MM POTASSIUM     
REMARK 210                                   PHOSPHATE, 95% H2O/5% D2O; 1 MM    
REMARK 210                                   [U-100% 13C; U-100% 15N] ACRA, 1   
REMARK 210                                   MM SUGAR (7-MER), 50 MM            
REMARK 210                                   POTASSIUM PHOSPHATE, 95% H2O/5%    
REMARK 210                                   D2O; 1 MM [U-100% 15N] ACRA, 1     
REMARK 210                                   MM SUGAR (7-MER), 50 MM            
REMARK 210                                   POTASSIUM PHOSPHATE, 100% D2O; 1   
REMARK 210                                   MM [U-100% 13C; U-100% 15N] ACRA,  
REMARK 210                                   1 MM SUGAR (7-MER), 50 MM          
REMARK 210                                   POTASSIUM PHOSPHATE, 100% D2O      
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D 1H-15N HSQC; 2D 1H-13C HSQC;    
REMARK 210                                   2D 1H-1H NOESY; 3D CBCA(CO)NH;     
REMARK 210                                   3D HNCA; 3D HN(CO)CA; 3D HCCH-     
REMARK 210                                   TOCSY; 3D 1H-13C NOESY; 3D 1H-     
REMARK 210                                   15N NOESY; 2D 13C FILTERED-        
REMARK 210                                   FILTERED NOESY; 2D 15N FILTERED-   
REMARK 210                                   FILTERED NOESY; 3D 13C EDITED-     
REMARK 210                                   FILTERED NOESY; 2D 13C FILTERED-   
REMARK 210                                   EDITED NOESY                       
REMARK 210  SPECTROMETER FIELD STRENGTH    : 500 MHZ; 600 MHZ; 750 MHZ; 900     
REMARK 210                                   MHZ                                
REMARK 210  SPECTROMETER MODEL             : AVANCE                             
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : SPARKY                             
REMARK 210   METHOD USED                   : DISTANCE GEOMETRY                  
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 1000                               
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 20                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LOWEST         
REMARK 210                                   ENERGY                             
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  1 PRO A   6     -167.12    -69.84                                   
REMARK 500  1 LEU A  16       56.17   -100.41                                   
REMARK 500  1 LYS A  25       97.53    -57.42                                   
REMARK 500  1 LEU A  29      -37.89   -136.52                                   
REMARK 500  1 ASP A  35       46.33    -91.30                                   
REMARK 500  1 GLN A  36       94.54   -173.16                                   
REMARK 500  1 SER A  38      165.08     67.40                                   
REMARK 500  1 ASP A  40       39.78   -159.46                                   
REMARK 500  1 PHE A  41      -65.15   -133.29                                   
REMARK 500  1 SER A  44      160.40     62.20                                   
REMARK 500  1 GLN A  50     -163.34   -177.53                                   
REMARK 500  1 GLU A  57       19.78   -152.09                                   
REMARK 500  1 TYR A  58      177.04    -55.16                                   
REMARK 500  1 THR A  64     -174.61   -179.83                                   
REMARK 500  1 ALA A  91     -154.01    -60.06                                   
REMARK 500  1 GLU A  95       52.04   -100.92                                   
REMARK 500  1 ASN A 101      165.62     69.25                                   
REMARK 500  1 LEU A 102      165.07     64.24                                   
REMARK 500  1 PRO A 104       96.15    -69.79                                   
REMARK 500  1 ALA A 107       73.15   -174.99                                   
REMARK 500  1 ASP A 108     -169.79   -111.53                                   
REMARK 500  1 SER A 110      -62.99    -94.83                                   
REMARK 500  1 HIS A 111     -174.98   -171.33                                   
REMARK 500  2 LEU A  16       50.25    -96.18                                   
REMARK 500  2 ASP A  21     -169.96   -107.79                                   
REMARK 500  2 LYS A  25       92.94    -57.21                                   
REMARK 500  2 ASP A  35       26.95   -162.34                                   
REMARK 500  2 PHE A  41      -80.46   -102.11                                   
REMARK 500  2 ASN A  42      136.00    179.45                                   
REMARK 500  2 ALA A  46      107.31   -162.33                                   
REMARK 500  2 SER A  49      -49.20   -175.48                                   
REMARK 500  2 GLN A  50       74.06   -168.77                                   
REMARK 500  2 ASP A  59     -172.85   -179.27                                   
REMARK 500  2 PHE A  74       10.98   -149.24                                   
REMARK 500  2 ASP A  75      165.57     76.30                                   
REMARK 500  2 ASN A  84     -169.62   -121.20                                   
REMARK 500  2 ALA A  91      -85.59    -67.21                                   
REMARK 500  2 ASN A 101       95.83     64.08                                   
REMARK 500  2 PRO A 104       97.95    -69.81                                   
REMARK 500  2 TYR A 106       28.88   -164.06                                   
REMARK 500  2 HIS A 111       89.90     59.12                                   
REMARK 500  2 HIS A 114      164.96     62.54                                   
REMARK 500  3 LEU A  16       48.87    -97.32                                   
REMARK 500  3 LYS A  25       96.50    -56.77                                   
REMARK 500  3 LEU A  29      -38.79   -135.65                                   
REMARK 500  3 ASP A  35       33.68    177.14                                   
REMARK 500  3 GLN A  36     -168.99     49.99                                   
REMARK 500  3 ALA A  37      -85.45    -66.14                                   
REMARK 500  3 SER A  38       41.82    179.82                                   
REMARK 500  3 ASP A  40      -30.60   -139.86                                   
REMARK 500                                                                      
REMARK 500 THIS ENTRY HAS     441 RAMACHANDRAN OUTLIERS.                        
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 15735   RELATED DB: BMRB                                 
REMARK 900 NONGLYCOSYLATED FORM                                                 
REMARK 900 RELATED ID: 2K32   RELATED DB: PDB                                   
REMARK 900 NONGLYCOSYLATED FORM                                                 
REMARK 900 RELATED ID: 15737   RELATED DB: BMRB                                 
DBREF  2K33 A    1    36  UNP    Q8RTE5   Q8RTE5_CAMJE    61     96             
DBREF  2K33 A   37    64  UNP    Q8RTE5   Q8RTE5_CAMJE   118    145             
DBREF  2K33 A   65   108  UNP    Q8RTE5   Q8RTE5_CAMJE   167    210             
SEQADV 2K33 GLN A   36  UNP  Q8RTE5    LYS    96 ENGINEERED MUTATION            
SEQADV 2K33 GLN A   50  UNP  Q8RTE5    LYS   131 ENGINEERED MUTATION            
SEQADV 2K33 GLY A  109  UNP  Q8RTE5              EXPRESSION TAG                 
SEQADV 2K33 SER A  110  UNP  Q8RTE5              EXPRESSION TAG                 
SEQADV 2K33 HIS A  111  UNP  Q8RTE5              EXPRESSION TAG                 
SEQADV 2K33 HIS A  112  UNP  Q8RTE5              EXPRESSION TAG                 
SEQADV 2K33 HIS A  113  UNP  Q8RTE5              EXPRESSION TAG                 
SEQADV 2K33 HIS A  114  UNP  Q8RTE5              EXPRESSION TAG                 
SEQADV 2K33 HIS A  115  UNP  Q8RTE5              EXPRESSION TAG                 
SEQADV 2K33 HIS A  116  UNP  Q8RTE5              EXPRESSION TAG                 
SEQRES   1 A  116  ASP VAL ILE ILE LYS PRO GLN VAL SER GLY VAL ILE VAL          
SEQRES   2 A  116  ASN LYS LEU PHE LYS ALA GLY ASP LYS VAL LYS LYS GLY          
SEQRES   3 A  116  GLN THR LEU PHE ILE ILE GLU GLN ASP GLN ALA SER LYS          
SEQRES   4 A  116  ASP PHE ASN ARG SER LYS ALA LEU PHE SER GLN SER ALA          
SEQRES   5 A  116  ILE SER GLN LYS GLU TYR ASP SER SER LEU ALA THR LEU          
SEQRES   6 A  116  ASP HIS THR GLU ILE LYS ALA PRO PHE ASP GLY THR ILE          
SEQRES   7 A  116  GLY ASP ALA LEU VAL ASN ILE GLY ASP TYR VAL SER ALA          
SEQRES   8 A  116  SER THR THR GLU LEU VAL ARG VAL THR ASN LEU ASN PRO          
SEQRES   9 A  116  ILE TYR ALA ASP GLY SER HIS HIS HIS HIS HIS HIS              
MODRES 2K33 ASN A   42  ASN  GLYCOSYLATION SITE                                 
HET    B6D  B   1      32                                                       
HET    A2G  B   2      27                                                       
HET    A2G  B   3      27                                                       
HET    A2G  B   4      26                                                       
HET    A2G  B   5      27                                                       
HET    A2G  B   6      27                                                       
HET    BGC  B   7      22                                                       
HETNAM     B6D 2,4-BISACETAMIDO-2,4,6-TRIDEOXY-BETA-D-GLUCOPYRANOSE             
HETNAM     A2G 2-ACETAMIDO-2-DEOXY-ALPHA-D-GALACTOPYRANOSE                      
HETNAM     BGC BETA-D-GLUCOPYRANOSE                                             
HETSYN     B6D 2,4-BIS(ACETYLAMINO)-2,4,6-TRIDEOXY-BETA-D-                      
HETSYN   2 B6D  GLUCOPYRANOSE; 2,4-DIACETAMIDO-2,4,6-TRIDEOXY-BETA-D-           
HETSYN   3 B6D  GLUCOPYRANOSE; BACILLOSAMINE; 2,4-BISACETAMIDO-2,4,6-           
HETSYN   4 B6D  TRIDEOXY-BETA-D-GLUCOSE; 2,4-BISACETAMIDO-2,4,6-                
HETSYN   5 B6D  TRIDEOXY-D-GLUCOSE; 2,4-BISACETAMIDO-2,4,6-TRIDEOXY-            
HETSYN   6 B6D  GLUCOSE                                                         
HETSYN     A2G N-ACETYL-ALPHA-D-GALACTOSAMINE; 2-ACETAMIDO-2-DEOXY-             
HETSYN   2 A2G  ALPHA-D-GALACTOSE; 2-ACETAMIDO-2-DEOXY-D-GALACTOSE; 2-          
HETSYN   3 A2G  ACETAMIDO-2-DEOXY-GALACTOSE; N-ACETYL-2-DEOXY-2-AMINO-          
HETSYN   4 A2G  GALACTOSE                                                       
HETSYN     BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE                               
FORMUL   2  B6D    C10 H18 N2 O5                                                
FORMUL   2  A2G    5(C8 H15 N O6)                                               
FORMUL   2  BGC    C6 H12 O6                                                    
SHEET    1   A 4 VAL A   2  ILE A   4  0                                        
SHEET    2   A 4 VAL A  97  THR A 100 -1  O  VAL A  99   N  VAL A   2           
SHEET    3   A 4 GLY A  76  ILE A  78 -1  N  THR A  77   O  THR A 100           
SHEET    4   A 4 LYS A  22  VAL A  23 -1  N  VAL A  23   O  GLY A  76           
SHEET    1   B 4 HIS A  67  LYS A  71  0                                        
SHEET    2   B 4 THR A  28  GLU A  33 -1  N  ILE A  32   O  THR A  68           
SHEET    3   B 4 GLY A  10  ASN A  14 -1  N  VAL A  13   O  ILE A  31           
SHEET    4   B 4 TYR A  88  VAL A  89 -1  O  VAL A  89   N  GLY A  10           
LINK         ND2 ASN A  42                 C1  B6D B   1     1555   1555  1.39  
LINK         O3  B6D B   1                 C1  A2G B   2     1555   1555  1.49  
LINK         O4  A2G B   2                 C1  A2G B   3     1555   1555  1.49  
LINK         O4  A2G B   3                 C1  A2G B   4     1555   1555  1.49  
LINK         O4  A2G B   4                 C1  A2G B   5     1555   1555  1.49  
LINK         O3  A2G B   4                 C1  BGC B   7     1555   1555  1.47  
LINK         O4  A2G B   5                 C1  A2G B   6     1555   1555  1.49  
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
MODEL        1